Skip to main content
Clinical Trials/NL-OMON51852
NL-OMON51852
Not yet recruiting
Phase 3

Drug-Coated Balloons versus Drug-Eluting Stents for Treatment of De-Novo Coronary Artery Lesions in Patients with Stable Coronary Artery Disease - the COATED Trial. - The COATED Trial

Vrije Universiteit Medisch Centrum0 sites230 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
arteriosclerosis
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
230
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \>\= 18 years
  • Stable angina or dyspnea and the presence of a single de\-novo lesion in a
  • native coronary artery causing myocardial ischemia, eligible for PCI based on a
  • formal local heart team decision
  • Reference diameter of the vessel is 2\.5\-4\.0 mm
  • The lesion is suitable for both treatment with DCB and DES

Exclusion Criteria

  • Dissection affecting the flow (TIMI score\<3\), significant recoil (\>30%) or
  • coronary perforation after predilation
  • Reference diameter of the vessel is \<2\.5 mm or \>4\.0 mm
  • Bifurcation lesion, requiring a two\-stent technique
  • In\-stent restenosis
  • Unprotected left main lesion
  • Chronic total occlusion
  • Acute cononary syndrome
  • Cardiogenic shock
  • Severe kidney disease defined as an eGFR \< 30 ml/min

Outcomes

Primary Outcomes

Not specified

Similar Trials